Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
1988.0000
8.30
(
0.42
%)
NSE
Sep 11, 2025
15:54 PM
Volume:
565.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
08 May 2024
US FDA Observation
1988.00
0.42%
Result Update:Lupin
Buy:
Lupin Ltd.
by
Axis Direct
Target: 1800
Target
Axis Direct
We have BUY on the stock
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended
Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal
Trendlyne Marketwatch |
11 Sep 2025, 04:07PM
India’s IPO story in 2025: Investors go selective, backing quality over hype
The Baseline |
11 Sep 2025, 03:50PM
Lupin expects normalization by September quarter
|
17 Apr 2020